Identity on this record
Chemical name: Semax (ACTH 4-10 analogue heptapeptide).
Common synonyms: MEHFPGP, ACTH(4-7)-PGP.
Sequence: Met-Glu-His-Phe-Pro-Gly-Pro.
CAS number: 80714-61-0 (registry entry).
Molecular formula: C37H51N9O10.
Molecular weight: 813.87 g/mol.
Appearance: White lyophilised powder.
Catalog strength: 10 mg vial.
Those identifiers describe Semax as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
SEMAX 10mg is the 10 mg lyophilized unit, listed at AED 349 before VAT. The product record stores that sealed unit at 2–8 °C.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Semax, not a delivered-cost quote. Ordering context that already exists for this compound: Semax research guide.
Lots and certificates
Lot VL-SEMAX-20260325 is the catalogue certificate for SEMAX 10mg. Read it on SEMAX 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Developed at the Institute of Molecular Genetics (Russian Academy of Sciences) in the 1980s–90s. International research supply interest grew around neuroprotection model literature.
Topics named on the Semax record, as literature context rather than as outcomes VaultLabs claims: Neuronal culture viability assays; BDNF expression panels; Ischemia-reperfusion models (preclinical); Cognitive behavior models (rodent literature).
That is context for identifying Semax. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the Semax monograph, so a reader can check them against that page:
Sequence is Met-Glu-His-Phe-Pro-Gly-Pro — an ACTH(4-7) fragment with a C-terminal Pro-Gly-Pro extension that slows enzymatic degradation.
CAS registry number 80714-61-0; molecular formula C37H51N9O10; molecular weight 813.87 g/mol.
Unlike the ACTH fragment it derives from, Semax is described in the literature as lacking corticotropic activity.
Research themes are neurotrophic factor expression, particularly BDNF, and cognitive and neuroprotective model systems.
Registered as a medicine in Russia; not approved by the UAE Ministry of Health and Prevention, the FDA or the EMA.
Dispatch and the research-use boundary
VaultLabs dispatches Semax from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the Semax compound monograph. Handling of the sealed unit is the Semax storage guide. Questions are collected on the Semax FAQ. How it differs from neighbouring records is the Semax comparison.